If your state uses a Medicaid managed care carve-in model for 340B, you are operating in the most compliance-risky environment in the program. The duplicate discount exposure is real, the reconciliation burden is heavy, and most covered entities are not doing it well enough to survive an audit finding.
Carve-In vs. Carve-Out: Why It Matters
In a carve-out state, Medicaid managed care organizations exclude 340B claims from their rebate submissions to manufacturers. The covered entity buys at 340B price, bills the MCO, and the manufacturer does not submit a rebate on that claim. Clean separation, minimal duplicate discount risk.
In a carve-in state, the MCO includes 340B claims in its rebate submissions. The covered entity still buys at 340B price, but now the manufacturer is also paying a rebate to the state on the same drug unit. That is a duplicate discount — the manufacturer is effectively discounting the drug twice — and it is illegal under the 340B statute.
The covered entity is responsible for preventing this. Not the MCO. Not the state. You.
The Reconciliation Problem
Preventing duplicate discounts in a carve-in state requires the covered entity to identify every 340B claim that was billed to a Medicaid MCO and ensure that claim is excluded from the state's rebate invoice to the manufacturer. In practice, this means submitting claims-level data to the state Medicaid agency or its designee so those claims can be carved out of the rebate file.
The problem is timing. Most states process rebate invoices quarterly. If your claims data submission is late, incomplete, or formatted incorrectly, those claims stay in the rebate file and you have a duplicate discount. Cleaning it up retroactively involves manufacturer disputes, state agency coordination, and potential repayment obligations.
What a Clean Process Looks Like
The covered entities that handle carve-in correctly do three things. First, they flag every 340B dispense at the point of sale with a modifier or identifier that marks it as a 340B claim. Second, they submit a complete file of 340B-flagged Medicaid MCO claims to the state agency monthly — not quarterly. Third, they reconcile the state's rebate exclusion file against their own records to confirm that every 340B claim they submitted was actually excluded.
If you are not doing all three, you have duplicate discount exposure. The question is not whether it exists — it is how large it is and whether HRSA or a manufacturer will find it before you do.
The Financial Stakes
Duplicate discount findings in HRSA audits result in repayment obligations. The covered entity must repay the manufacturer for the 340B discount on every claim where a duplicate discount occurred. For organizations with significant Medicaid MCO volume, these repayments can reach six figures. Add the administrative cost of the audit response, the corrective action plan, and the reputational damage, and carve-in compliance failures become one of the most expensive mistakes a 340B program can make.
If you operate in a carve-in state and your last duplicate discount reconciliation was more than 90 days ago, stop reading and go run one. The exposure is accumulating every day you wait.